drugset / Trial / NCT00669149
Anticoagulant Treatments and Percutaneous Coronary Angioplasty
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether adjunction of intravenous anticoagulant therapy (enoxaparin, HNF, bivalirudin) to antiaggregation with clopidogrel and aspirin improves in-hospital results of percutaneous transluminal coronary angioplasty (ptca) in selected patients.
Timeline
- Start
- 2008-06
- Primary completion
- 2013-08-03
- Completion
- 2013-08-03
Outcome
Outcome not reported
Stopped (Enrollment): “recruitment difficulties”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bivalirudin | Peptide | — | Intravenous |
| Comparator | Enoxaparin sodium | Other / unclassified | — | Intravenous |
| Comparator | Heparin | Other / unclassified | — | Intravenous |
| Background | Aspirin | Small molecule | — | — |
| Background | Clopidogrel | Small molecule | — | — |